Comparison between Anthem Biosciences IPO and GSP Crop Science IPO.
Anthem Biosciences IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while GSP Crop Science IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Anthem Biosciences IPO is up to ₹3,395.00 Cr whereas the issue size of the GSP Crop Science IPO is up to ₹400.00 Cr. The final issue price of Anthem Biosciences IPO is ₹570.00 per share and of GSP Crop Science IPO is ₹320.00 per share.
| Anthem Biosciences IPO | GSP Crop Science IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹10 per share |
| Issue Price (Lower) | ₹540.00 per share | ₹304.00 per share |
| Issue Price (Upper) | ₹570.00 per share | ₹320.00 per share |
| Issue Price (Final) | ₹570.00 per share | ₹320.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ₹50.00 per share | |
| Market Lot Size | 26 shares | 46 shares |
| Fresh Issue Size | 0 shares | 75,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹240.00 Cr |
| OFS Issue Size | 5,95,75,319 shares | 50,00,000 shares |
| OFS Issue Size (Amount) | up to ₹3,395.00 Cr | up to ₹160.00 Cr |
| Issue Size Total | 5,95,75,319 shares | 1,25,00,000 shares |
| Issue Size Total (Amount) | up to ₹3,395.00 Cr | up to ₹400.00 Cr |
Anthem Biosciences IPO opens on Jul 14, 2025, while GSP Crop Science IPO opens on Mar 16, 2026. The closing date of Anthem Biosciences IPO and GSP Crop Science IPO is Jul 16, 2025, and Mar 18, 2026, respectively.
| Anthem Biosciences IPO | GSP Crop Science IPO | |
|---|---|---|
| Anchor Bid Date | Jul 11, 2025 | Mar 13, 2026 |
| Issue Open | Jul 14, 2025 | Mar 16, 2026 |
| Issue Close | Jul 16, 2025 | Mar 18, 2026 |
| Basis Of Allotment (Tentative) | Jul 17, 2025 | Mar 20, 2026 |
| Initiation of Refunds (Tentative) | Jul 18, 2025 | Mar 23, 2026 |
| Credit of Share (Tentative) | Jul 18, 2025 | Mar 23, 2026 |
| Listing date (Tentative) | Jul 21, 2025 | Mar 24, 2026 |
| Anchor Lockin End date 1 | Aug 15, 2025 | Apr 19, 2026 |
| Anchor Lockin End date 2 | Oct 14, 2025 | Jun 18, 2026 |
Anthem Biosciences IPO P/E ratio is 70.62, as compared to GSP Crop Science IPO P/E ratio of 15.34.
| Anthem Biosciences IPO | GSP Crop Science IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Anthem Biosciences Ltd.'s revenue increased by 30% and profit after tax (PAT) rose by 23% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 76.87 | 98.32 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 74.68 | 71.72 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 70.62 | 15.34 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹31867.39 Cr. | ₹1488.60 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 20.82% | 18.38% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 26.88% | 19.80% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.05 | 0.58 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹8.07 | ₹20.87 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 20.82% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Anthem Biosciences IPO Retail Individual Investors (RII) are offered 2,07,95,834 shares while in GSP Crop Science IPO retail investors are offered 2,07,95,834 shares. Qualified Institutional Buyers (QIB) are offered 1,18,83,333 shares in Anthem Biosciences IPO and 25,00,000 shares in GSP Crop Science IPO.
| Anthem Biosciences IPO | GSP Crop Science IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,78,24,999 shares | 37,50,000 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 1,18,83,333 shares | 25,00,000 shares |
| NII | 89,12,500 shares | 18,75,000 shares |
| RII | 2,07,95,834 shares | 43,75,000 shares |
| Employee | 1,58,653 shares | 0 shares |
| Others | ||
| Total | 5,95,75,319 shares | 1,25,00,000 shares |
Anthem Biosciences IPO subscribed 67.42x in total, whereas GSP Crop Science IPO subscribed 1.64x.
| Anthem Biosciences IPO | GSP Crop Science IPO | |
|---|---|---|
| QIB (times) | 192.80x | 2.66x |
| NII (times) | 44.70x | 3.14x |
| Big NII (times) | 51.66x | 4.11x |
| Small NII (times) | 30.80x | 1.20x |
| RII (times) | 5.98x | 0.42x |
| Employee (times) | 6.99x | |
| Other (times) | ||
| Total (times) | 67.42x | 1.64x |
